Orexo AB
STO:ORX

Watchlist Manager
Orexo AB Logo
Orexo AB
STO:ORX
Watchlist
Price: 24.5 SEK 0.82% Market Closed
Market Cap: 850.4m SEK

EV/EBIT
Enterprise Value to EBIT

-8.3
Current
-6.5
Median
16.6
Industry
Lower than median
Lower than industry value

Enterprise Value to EBIT (EV/EBIT) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s earnings before interest and taxes (EBIT). Considered one of the most frequently used multiples for comparisons among companies, the EV/EBIT multiple relies on operating income as the core driver of valuation.

EV/EBIT
-8.3
=
Enterprise Value
1.2B SEK
/
EBIT
-145.9m SEK
All Countries
Close
Market Cap EV/EBIT
SE
Orexo AB
STO:ORX
845.4m SEK -8.3
US
Eli Lilly and Co
NYSE:LLY
971.9B USD 38
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 17 702.3
US
Johnson & Johnson
NYSE:JNJ
509.1B USD 21.5
CH
Roche Holding AG
SIX:ROG
252.3B CHF 13.4
UK
AstraZeneca PLC
LSE:AZN
208.5B GBP 158
CH
Novartis AG
SIX:NOVN
202.4B CHF 14.5
US
Merck & Co Inc
NYSE:MRK
249.5B USD 11.1
DK
Novo Nordisk A/S
CSE:NOVO B
1.4T DKK 11.2
IE
Endo International PLC
LSE:0Y5F
209B USD 830.4
US
Pfizer Inc
NYSE:PFE
147B USD 10.4
EBIT Growth EV/EBIT to Growth
SE
Orexo AB
STO:ORX
Average EV/EBIT: 1 881.1
Negative Multiple: -8.3
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
38
36%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
21.5
15%
1.4
CH
Roche Holding AG
SIX:ROG
13.4
5%
2.7
UK
AstraZeneca PLC
LSE:AZN
158
23%
6.9
CH
Novartis AG
SIX:NOVN
14.5
12%
1.2
US
Merck & Co Inc
NYSE:MRK
11.1
8%
1.4
DK
Novo Nordisk A/S
CSE:NOVO B
11.2
1%
11.2
IE
E
Endo International PLC
LSE:0Y5F
830.4
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.4
8%
1.3

EV/EBIT Forward Multiples

Forward EV/EBIT multiple is a version of the EV/EBIT ratio that uses forecasted EBIT for the EV/EBIT calculation. 1-Year, 2-Years, and 3-Years forwards use EBIT forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBIT
hidden
2-Years Forward
EV/EBIT
hidden
3-Years Forward
EV/EBIT
hidden